4//SEC Filing
SAVIENT PHARMACEUTICALS INC 4
Accession 0001230295-07-000789
CIK 0000722104operating
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 10:00 AM ET
Size
14.7 KB
Accession
0001230295-07-000789
Insider Transaction Report
Form 4
Lamm Robert
SVP, Quality & Reg. Affairs
Transactions
- Exercise/Conversion
Common Stock, $.01 par value per share
2007-12-19$4.67/sh+4,433$20,702→ 46,851 total - Sale
Common Stock, $.01 par value per share
2007-12-19$20.75/sh−4,433$91,984→ 42,418 total - Exercise/Conversion
Common Stock, $.01 par value per share
2007-12-19$2.97/sh+567$1,684→ 42,985 total - Exercise/Conversion
Option to Purchase Common Stock, $.01 par value
2007-12-19$4.67/sh−4,433$20,702→ 567 totalExercise: $4.67From: 2003-06-10Exp: 2012-06-10→ Common Stock, $.01 par value per share (4,433 underlying) - Sale
Common Stock, $.01 par value per share
2007-12-19$20.75/sh−567$11,765→ 42,418 total - Exercise/Conversion
Option to Purchase Common Stock, $.01 par value
2007-12-19$2.97/sh−567$1,684→ 26,433 totalExercise: $2.97From: 2004-01-22Exp: 2013-01-22→ Common Stock, $.01 par value per share (567 underlying)
Footnotes (1)
- [F1]This sale was made pursuant to a trading plan adopted on June 14, 2007 by the reporting person in accordance with Rule 105b-1 under the Securities Exchange Act of 1934.
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000722104
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 10:00 AM ET
- Size
- 14.7 KB